Healthy volunteers needed to test new Drug's safety
NCT ID NCT07444294
First seen Mar 11, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This early-stage study is testing a new drug called SRK-439 in 76 healthy adults aged 18 to 55. The main goal is to see if the drug is safe and how the body processes it. Participants will receive either a single dose or multiple doses of the drug. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medpace CPU
RECRUITINGCincinnati, Ohio, 45227, United States
Conditions
Explore the condition pages connected to this study.